Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing. We support a large global customer base which includes hospitals to large corporates.
Microgen Bioproducts develop, manufacture and distribute high quality diagnostic products for clinical and food laboratories.
Novacyt Group History
Novacyt has noticeably evolved since the acquisition of Lab 21 in June 2014.
Inception of Lab 21 (Microgen, Biotec, Plasmatec and Lab 21)
Inception of Novacyt SA
Initial commercial launch of NOVAPREP®
Listing of Novacyt on Alternext Paris
Acquisition of Lab 21
Acquisition of Primer Design
Admission onto AIM London Stock Market
Sale of Lab21 Clinical Lab
Sale of NOVAprep
Worlds first CE-IVD COVID-19 kits
Acquisition of IT-IS International Ltd.
Within the Novacyt Group, we are committed to Quality as a fundamental part of all its business activities and strives to meet and exceed external and internal customer expectations. As a learning organisation we will continuously drive innovation, improvements and excellence for all our products and services whilst meeting all regulatory requirements for the markets we serve.
To support this, we have established this Quality Policy and have the following Quality Objectives:
To implement and maintain a Quality Management System that complies with the requirements laid down in the IVD Directive (98/79/EC), EN ISO 13485:2012 and other regulations as required to support business activities
To monitor and measure the performance of both the products we sell, and the systems and processes we operate to identify and implement continuous improvements
To ensure that the importance of Quality is communicated to all employees throughout the business through regular information updates, and that employees are trained and supported to deliver good products and services
To involve all employees in owning and improving the Quality Management System to the benefit of customers, employees and other stakeholder groups
To place Quality as a fundamental cornerstone of annual business strategic planning
This Quality Policy will be reviewed annually for continuing suitability.